ARQ Wealth Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Buy
11,443
+769
+7% +$85.7K 0.15% 110
2026
Q2
$1.16M Buy
10,674
+1,644
+18% +$170K 0.14% 109
2026
Q1
$938K Buy
+9,030
New +$962K 0.17% 99

Other funds holding PPH

ARQ Wealth Advisors's PPH Position: Q3 2026 in Review

ARQ Wealth Advisors increased its VanEck Pharmaceutical ETF (PPH) stake by 7.2% in Q3 2026, buying an estimated $85.7K and bringing the position to 11,443 shares worth $1.25M. The position accounts for 0.15% of the portfolio, ranked #110.

ARQ Wealth Advisors first reported a position in PPH in Q1 2026 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • ARQ Wealth Advisors held 11,443 shares of VanEck Pharmaceutical ETF worth $1.25M as of Q3 2026.
  • ARQ Wealth Advisors bought 769 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $85.7K.
  • VanEck Pharmaceutical ETF made up 0.15% of ARQ Wealth Advisors's portfolio in Q3 2026, its #110 holding.
  • ARQ Wealth Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on ARQ Wealth Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.